THIRTYFIVEBIO
THIRTYFIVEBIO
Social Links:
Industry:
Biotechnology
Founded:
2021-01-01
Address:
Abingdon, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.30fivebio.com
Total Employee:
11+
Status:
Active
Total Funding:
1.14 M GBP
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Global Site Tag ReCAPTCHA
Similar Organizations
Aachen Proteineers
Aachen Proteineers provides biotechnology.
Aldebaran Therapeutics
Aldebaran Therapeutics is a biotechnology company.
AlphaThera
AlphaThera is a biotechnology industry.
Geneius
Geneius is a Biotechnology company.
Libra Therapeutics
Libra Therapeutics is a biotechnology company.
Magpie Pharmaceuticals
Magpie Pharmaceuticals is a biotechnology company.
Repertoire Genesis
Repertoire Genesis is a biotechnology company.
RNADerm Therapeutics
RNADerm Therapeutics is a biotechnology company.
The Liver Company
The Liver Company is a biotechnology company.
Current Employees Featured
Investors List
Innovate UK
Innovate UK investment in Grant - ThirtyFiveBio
Innovate UK
Innovate UK investment in Grant - ThirtyFiveBio
Official Site Inspections
http://www.30fivebio.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "ThirtyFiveBio"
ThirtyFiveBio - LinkedIn
ThirtyFiveBio | 1,106 followers on LinkedIn. Applying proprietary understanding of GPR35 biology to develop novel small-molecule modulators. | ThirtyFiveBio is an early-stage drug discovery ...See details»
ThirtyFiveBio - Crunchbase Company Profile & Funding
ThirtyFiveBio is a biotechnology agency. GPR35 Antagonist Program: Developing small molecule inhibitors targeting GPR35 for gastrointestinal diseases and cancers.See details»
ThirtyFiveBio 2025 Company Profile: Valuation, Funding
Www.30fivebio.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. Milton Park Innovation Centre; 99 Park Drive, Milton Park; …See details»
THIRTYFIVEBIO LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for THIRTYFIVEBIO LIMITED of ABINGDON. Get the latest business insights from Dun & …See details»
ThirtyFiveBio - Overview, News & Similar companies - ZoomInfo
Mar 30, 2023 Who is ThirtyFiveBio. ThirtyFiveBio is an early-stage drug discovery company that was established in 2021 by a team of experienced pharmaceutical industry professionals and …See details»
ThirtyFiveBio - Leadership Team - The Org
The Leadership Team at ThirtyFiveBio is responsible for steering the company's strategic direction, overseeing operational management, and driving the core mission of discovering …See details»
About - ThirtyFiveBio
Cookie Duration Description; _ga: 1 year 1 month 4 days: Google Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report.See details»
ThirtyFiveBio Stealth Emergence - ThirtyFiveBio
Mar 27, 2023 ThirtyFiveBio is headquartered at the Innovation Centre on Milton Park, a key science precinct south of Oxford, UK. For more information, please visit: www.30fivebio.com Contacts: ThirtyFiveBio James Westcott Chief …See details»
ThirtyFiveBio - Company Profile - Tracxn
ThirtyFiveBio - Developing small molecule inhibitors targeting G protein coupled receptor. Founded by Kirsty McCarthy, Peter Joyce and 2 others in the year 2021. ThirtyFiveBio has 4 …See details»
ThirtyFiveBio - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
ThirtyFiveBio Emerges From Stealth with Presentation of
Mar 30, 2023 ThirtyFiveBio is headquartered at the Innovation Centre on Milton Park, a key science precinct south of Oxford, UK. For more information, please visit: www.30fivebio.com. …See details»
ThirtyFiveBio Company Overview, Contact Details & Competitors
Jul 2, 2024 [email protected]: 50%. See more formats. Frequently Asked Questions Where is ThirtyFiveBio 's headquarters located? ThirtyFiveBio 's main headquarters is located at 99 …See details»
Home - ThirtyFiveBio
Cookie Duration Description; _ga: 1 year 1 month 4 days: Google Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report.See details»
ThirtyFiveBio Emerges From Stealth with Presentation of First Data …
Mar 30, 2023 For more information, please visit: www.30fivebio.com. Contacts: ThirtyFiveBio James Westcott Chief Executive Officer P: +44 (0)1235 644980 [email protected]See details»
ThirtyFiveBio on LinkedIn: #bio2023 #biointernationalconvention # ...
Connect with us at BIO International Convention 2023! We are delighted to announce that ThirtyFiveBio CEO James Westcott, Co-Founder and Exec Chair Tom…See details»
Team - ThirtyFiveBio
GPR35 and drug discovery specialists applying our knowledge to develop small molecule antagonists of the GPCR GPR35 for the treatment of serious digestive system disorders.See details»
ThirtyFiveBio - Craft
ThirtyFiveBio is a company specializing in biotechnology research. It is focused on finding therapies for patients affected by GPR35. The company offers treatment for ulcerative colitis …See details»
MTM – Portfolio: ThirtyFiveBio
Precision treatment of digestive system disorders. Founded upon a deep understanding of the biology of GPR35, this group of drug discovery specialists is targeting the causal and …See details»
ThirtyFiveBio Closes Bridge Round of Financing Highlighted by …
6 days ago Capital will Support Continued Development of First-in-Class GPR35 Inhibitor Program for the Treatment of Ulcerative Colitis Utilizing Biomarker-Driven, Precision Medicine …See details»
Latest News - ThirtyFiveBio
ThirtyFiveBio Limited, a biotechnology company developing first-in-class small molecule inhibitors of G protein-coupled receptor 35 (GPR35) for the treatment of gastrointestinal (GI) disease, …See details»